Compared with standard-dose (SD), high-dose radiotherapy (RT) with concurrent chemotherapy (CT) did not improve overall survival of patients with stage III non-small-cell lung cancer (NSCLC), results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) have indicated. Philadelphia, PA-Of all the patients in the US with lung cancer, the country's leading cause of cancer death, 75 to 80 percent of them have NSCLC, with ...Saturday, 1 June 2013
Survival in Patients With Stage III Lung Cancer Hampered by Higher Dose of Radiotherapy
Compared with standard-dose (SD), high-dose radiotherapy (RT) with concurrent chemotherapy (CT) did not improve overall survival of patients with stage III non-small-cell lung cancer (NSCLC), results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) have indicated. Philadelphia, PA-Of all the patients in the US with lung cancer, the country's leading cause of cancer death, 75 to 80 percent of them have NSCLC, with ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment